Welcome to this week’s edition of The Private Capital Compass, a curated weekly analysis from Private Capital Global designed to cut through the noise and surface what matters most and what it means for investors and operators.

This week, Bain & Company releases its 2026 Global Private Equity Report with numbers that look impressive on the surface. Private credit shows its first real signs of stress as BDC redemptions breach limits and refinancing pressure mounts across the market. BlackRock and EQT make a $33.4 billion statement on energy infrastructure and the AI power buildout, while family offices commit to a record $189 billion in startup funding in February, nearly all of it concentrated in AI.

In this edition, we examine what Bain's 2026 outlook actually signals beneath the megadeal headlines and why the structural challenges facing the industry demand more than one strong year of deal volume to resolve. We look at how life sciences PE is rewriting its M&A playbook around precision and post-close execution, and what that shift signals for the broader market. EY's latest research makes the case that data readiness is no longer a back-office function but a front-line value creation priority. We break down the private credit stress test underway in BDC markets and what it means for sponsors who built their financing strategies around that capital.

Compass Points

PCG’s Recap and Take on the Stories of the Week

• Megadeals, Muted Recovery: Private equity posted its second-best year on record in 2025, with global buyout value climbing 44% to $904 billion and exit value surging 47% to $717 billion, according to Bain & Company's 2026 Global Private Equity Report. But the headline numbers obscure a more complicated picture. Just 13 megadeals above $10 billion accounted for 69% of total deal value growth, deal count fell 6% year over year, and distributions as a percentage of NAV have remained below 15% for four consecutive years, an industry record. Fundraising for buyout funds dropped 16%, dry powder sits at $1.3 trillion and is aging, and the average holding period at exit has stretched to seven years, with IRR data showing returns stagnate around that mark and deteriorate beyond it. The recovery is real, but it is narrow, concentrated, and sitting on top of structural challenges that one strong year of megadeal volume does not resolve.

  PCG Take: The Bain report is a useful reality check for GPs tempted to read 2025's headline numbers as a broad industry recovery. It wasn't. It was a megadeal rally in a market that is still working through a liquidity hangover, compressed fundraising, and the uncomfortable reality that multiple expansion is no longer a reliable value lever. 

• How Life Sciences PE Is Rewriting Its M&A Playbook: Life sciences private equity is entering 2026 with renewed momentum, but the dealmaking logic has fundamentally changed, according to CLA's assessment of the current market across biopharma, MedTech, and healthcare services. Sponsors are underwriting fewer deals with higher conviction, prioritizing late-stage, revenue-generating assets with near-term impact over assets requiring significant scientific or regulatory reinvention. Capital remains available, but investment committees are demanding clearer downside protection, faster paths to value realization, and more rigorous quality of earnings analysis.The most notable operational shift is in post-close execution: integration planning is beginning earlier in the diligence process, operating partners are engaged before the deal closes, and performance metrics are being defined upfront rather than retrofitted after close. 

  PCG Take: The life sciences market is functioning as a leading indicator for where the broader PE market is heading. The move from volume-driven platform building to high-conviction, execution-focused dealmaking reflects the same structural pressures Bain identified across the industry,  expensive assets, compressed exit windows, and LPs who are no longer patient with theoretical upside. 

• Why Data Readiness Is Now a Value Creation Imperative: Exit readiness has always mattered in private equity, but according to EY-Parthenon's latest research, the data foundation underpinning that readiness has become one of the most consequential variables in exit outcomes. Nearly 72% of PE firms identify weak data and KPI reporting as the biggest finance issue at exit, while 65% struggle to accurately reflect value creation initiatives in reported EBITDA, and 41% lack the data granularity needed to substantiate their equity story to buyers. In a market where buyers are more cautious, diligence is more rigorous, and exit windows remain constrained, those gaps translate directly into valuation discounts, extended timelines, and deal friction. EY's research and case studies make the remediation timeline clear: data exit readiness efforts should begin at least 12 months before a planned exit, and ideally 24 months out. In one case study, early data remediation reduced churn by 20% and supported a 10x multiple exit at five times the original investment. In another, addressing reporting fragmentation across five business units resulted in a 15% EBITDA increase before the sale process even launched.

  PCG Take: The EY findings reframe a problem the industry has historically treated as a back-office issue into a front-line value creation priority. Weak data doesn't just complicate diligence, it actively destroys value at the moment of maximum scrutiny. For operating partners, this is a direct mandate: data governance and reporting infrastructure need to be on the value creation agenda from Day One of ownership, not quarterbacked by the CFO in the twelve months before a process launches. 

• Why Family Offices Are Ignoring the AI Bubble Narrative: Despite market turbulence and growing concerns about an AI valuation bubble, family offices accelerated their direct investment activity in AI-related startups throughout February, according to CNBC reporting on exclusive Fintrx data. Family offices made 41 direct investments in February, nearly all in AI-related companies, a level of concentration that reflects deliberate conviction rather than passive trend-following. The activity coincided with a record-breaking month for startup fundraising broadly, with AI-related companies raising $171 billion and total startup funding reaching $189 billion for the month, per Crunchbase. Notable family office commitments included Emerson Collective joining a $1 billion raise for World Labs and Azim Premji's family office participating in a $315 million Series E for AI video generation startup Runway. 

  PCG Take: Family offices are behaving exactly as you would expect sophisticated, long-duration capital to behave, they are looking through the noise. The dot-com comparison that dominates AI bubble discourse misses a critical distinction: today's leading AI investments are being underwritten by some of the most analytically rigorous capital allocators in the world, at firms with the balance sheet flexibility to absorb short-term volatility. For private equity, the more relevant signal is what this capital concentration means for the competitive landscape.

• Private Credit Faces a 'Show Me the Money' Moment: The private credit market is facing its most visible stress test since its decade-long expansion, according to Reuters. Business development companies — the tax-advantaged vehicles that major managers including Blackstone, Ares, Blue Owl, and KKR used to raise capital from individual investors, are now experiencing meaningful redemption pressure. The median listed BDC is trading at just 73% of stated net asset value, while nontraded vehicles are seeing withdrawal requests breach their standard quarterly caps. Blackstone's BCRED reported redemption requests equivalent to 7.9% of shares, and Blue Owl agreed to redeem 15% of assets in one aging fund. Healthcare providers, consumer products companies, and other borrowers are showing elevated payment stress, with loans paying interest in non-cash form jumping to 6.4% of the total at year-end 2025. With $12.7 billion in BDC debt maturities requiring refinancing this year, the pressure on managers to demonstrate conviction in their own portfolios is mounting and some, including Blackstone, have begun investing their own capital into their vehicles to signal confidence.

  PCG Take: Private credit's "show me the money" moment is a healthy, if uncomfortable, reckoning for an asset class that expanded rapidly on the back of favorable conditions and retail investor appetite. For private equity sponsors, the implications are practical and immediate. The firms that built their financing strategies around private credit's seemingly unlimited availability need to stress-test those assumptions. Refinancing costs are rising, lender flexibility is compressing, and the credit quality conversation that was largely absent during the expansion years is now front and center in diligence.

Deal Spotlight:  BlackRock and EQT Move on AES in $33.4B Infrastructure Play

Transaction: A consortium led by BlackRock's Global Infrastructure Partners (GIP) and the EQT Infrastructure VI fund, alongside co-underwriters CalPERS and the Qatar Investment Authority, entered into a definitive agreement to acquire AES Corporation at $15.00 per share in cash, representing a total equity value of $10.7 billion and an enterprise value of approximately $33.4 billion, including the assumption of existing debt. The transaction carries a 40.3% premium to the 30-day volume-weighted average share price prior to July 8, 2025, the last full trading day before the first media reports of a potential deal. The transaction is expected to close in late 2026 or early 2027. 

AES Chairman Jay Morse cited the need for significant capital to support growth beyond 2027, noting that without the transaction the company would likely have faced dividend reductions or substantial equity issuances. The deal brings together two of the world's most formidable infrastructure platforms, one of the largest public pension funds, and a sovereign wealth fund, a consortium structure that itself signals the scale of conviction behind the energy infrastructure thesis.

Why It Matters: The GIP-EQT consortium is making a definitive statement: infrastructure required to power the AI economy is the defining investment theme of this cycle. AES currently holds nearly 12 GW of signed agreements to supply power to major technology firms, making it far more than a legacy utility, it is a contracted clean energy platform with direct exposure to the most capital-intensive build-out in recent memory. This deal follows Blackstone's $11.5 billion acquisition of utility company TXNM, confirming that the convergence of private capital and regulated utilities is becoming a deliberate, repeatable strategy among the largest infrastructure managers globally. The consortium structure here also reflects how mega-scale energy deals are increasingly being capitalized through co-investment structures that distribute risk while allowing managers to pursue assets at enterprise values that would otherwise strain fund-level concentration limits.

For private equity and infrastructure investors, the AI-to-energy pipeline is creating durable, long-dated cash flow assets with contracted revenue, precisely the profile institutional LPs are seeking in volatile markets. For operating partners and portfolio company executives, the signal is more immediate: energy cost and energy access are rapidly becoming strategic variables, not operational afterthoughts. Companies with energy-intensive operations should be stress-testing their power procurement strategies now. The private capital community is voting with $33 billion that electricity supply will be constrained, expensive, and competitively advantaged for years to come.

Deep Dive: From AI Hype to EBITDA — What the 2026 AI Value Creation Summit Actually Taught Us

The 2026 ATX AI Value Creation Summit brought together operating partners and portfolio company executives for two days in Austin to move past the noise and into the mechanics of what actually matters: how does artificial intelligence drive measurable value in PE-backed businesses? The answer that emerged was deceptively simple,  AI transforms an operating team's ability to scale with lower headcount and greater efficiency. The leverage is real, but only when implementation is disciplined.

Start With the Problem, Not the Technology

The opening workshop set the right tone by refusing to start with tools. Before any discussion of models, platforms, or automation, the session reframed the question: where are we underperforming, and how can intelligent automation improve that result? Working through a mid-market manufacturing case study, the group mapped friction points and workflow failures before building a single agent. The sequencing matters enormously. If your workflow is broken, AI will automate the break.

Two principles emerged that apply broadly across industries and holding periods. First, design thinking is non-negotiable,  improvement begins with perspective, not technology. Second, the goal is a clean, end-to-end agentic workflow, not the "ping-pong problem" of Human → Agent → Human → Agent, which is friction with a better interface. Underpinning both: bring AI to the data, never move the data to the AI. Fragmented, poorly governed data doesn't get smarter with AI layered on top — it produces noise at scale.

Connecting AI to EBITDA

AI implementation must connect directly to EBITDA. Not pilot programs, not proof-of-concept exercises, but a focused portfolio of initiatives aligned with a clear investment thesis. One organizing framework that resonated: think about AI across four vectors simultaneously: embedding it into products, running it on infrastructure, using it to operate the business, and delivering AI-enabled capability through partnerships. Product, platform, operations, and ecosystem.

One presenter shared that after investing in four concise AI training modules, 93% of employees completed them voluntarily. That level of engagement reflects a leadership posture that invited people into the transformation rather than mandating it from above. AI cannot be delegated to IT. Executive ownership is the mechanism by which value remains measurable and defensible.

Governance and Data as Value Creation Variables

Two dimensions that don't get enough attention in value creation conversations were given significant time on the agenda. First was security: AI governance is a value creation variable. Strong governance reduces buyer friction, shortens diligence cycles, and protects exit multiples. On data, the summit reinforced that customer, product, and partner data are strategic assets sitting underutilized on most portfolio company balance sheets. Cross-sell modeling, churn prediction, and lifetime value analysis are no longer SaaS-exclusive capabilities. AI makes them systematic in sectors that have historically relied on instinct and relationship. 

Where ROI Actually Shows Up

The summit focused on the overlooked areas of the operating model where AI delivers near-term, measurable return. Procurement optimization surfaced as an immediate lever, AI identifying duplicate vendor agreements and cost savings that had gone unnoticed in manual processes. Hyper-personalized outreach demonstrated improvements in meeting quality and conversion rates through sharper pre-call intelligence. Customer support transformation showed how structured AI deployment improves consistency and efficiency without sacrificing quality.

The window for treating AI as a future priority is closing. Portfolio value creation teams that are still in evaluation mode are falling behind peers who are already capturing margin and compressing costs through disciplined deployment. The firms generating real returns from AI are doing it by identifying three to five high-friction, high-frequency processes and automating them with intention. That's where the EBITDA impact is showing up today.

As you assess your current portfolio, three questions are worth sitting with. Where are your portfolio companies losing margin to manual, repetitive processes that AI could systematically eliminate? Is your data governed well enough to actually leverage AI, or are you building on a fragmented foundation? And critically, who owns AI implementation at the executive level in each portfolio company?

Closing Remarks

Thank you for reading this week’s edition of The Private Capital Compass. Throughout 2026, PCG will convene investors, operators, and advisors through a growing slate of curated events in Austin, Boston, Chicago, London, New York, and San Francisco, each designed to move beyond surface-level discussion toward practical insights, peer exchange, and real-world application.

Our mission remains consistent: to deliver clear-eyed analysis, relevant intelligence, and informed perspective that helps private capital professionals translate market signals into durable value across deals, portfolios, and platforms.

We appreciate your continued engagement and look forward to navigating the year ahead together.

PCG Resources

Explore Upcoming Events: Private Capital Global hosts executive-level summits, roundtables, and curated gatherings for private capital investors and operators. → PCG Events Homepage | BOS Medtech Capital Connect Dealmaker Conference | NY Operating Partner Summit - Apr 23 | CHI Value Creation Exchange - May 14

Listen & Learn: Podcasts and Webinars: Access our Private Capital Insiders podcast hosted by Frank Scarpelli with leading dealmakers, operating partners, and portfolio executives on the trends shaping private markets. → PCG Podcasts & Webinars

Insights & Analysis: Access original PCG research, market commentary, and thought leadership focused on value creation, deal execution, and portfolio performance. → PCG Blogs